Journey Medical Corporation DERM Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's accounts receivable?
- Journey Medical Corporation (DERM) reported accounts receivable of $24.99M in Q1 2026.
- How has Journey Medical Corporation's accounts receivable changed year-over-year?
- Journey Medical Corporation's accounts receivable increased by 38.7% year-over-year, from $18.03M to $24.99M.
- What is the long-term trend for Journey Medical Corporation's accounts receivable?
- Over 5 years (2020 to 2025), Journey Medical Corporation's accounts receivable has grown at a 4.5% compound annual growth rate (CAGR), from $23.93M to $29.78M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.